DEUTSCHE GESELLSCHAFT FÜR PÄDIATRISCHE KARDIOLOGIE UND ANGEBORENE HERZFEHLER e.V.

Beschlossen vom Vorstand der Deutschen Gesellschaft für Pädiatrische Kardiologie und Angeborene Herzfehler e.V. am 15.11.2021

Publikationsverlauf

Artikel online veröffentlicht:
11. Februar 2025

• Literatur

• 1 Shinebourne EA, Babu-Narayan SV, Carvalho JS. Tetralogy of Fallot: from fetus to adult. Heart 2006; 92 (09) 1353-1359
• 2 Apitz C, Webb GD, Redington AN. Tetralogy of Fallot. Lancet 2009; 374 (9699) 1462-1471
• 3 Doyle T, Kavanaugh-McHugh A. Pathophysiology, clinical features, and diagnosis of tetralogy of Fallot. Armsby C, Conolly HM, Triedman JK. ed. UpToDate Inc; https://www.uptodate.com/contents/pathophysiology-clinical-features-and-diagnosis-of-tetralogy-of-Fallot (abgerufen Oktober 2020)
• 4 Lindinger A, Schwedler G, Hense HW. Prevalence of congenital heart defects in newborns in Germany: Results of the first registration year of the PAN Study (July 2006 to June 2007). Klin Padiatr 2010; 222 (05) 321-326
• 5 Bertranou EG, Blackstone EH, Hazelrig JB, Turner Jr ME, Kirklin JW. Life expectancy without surgery in tetralogy of Fallot. Am J Cardiol 1978; 42 (03) 458-466
• 6 Goldmuntz E, Clark BJ, Mitchell LE. et al. Frequency of 22q11 deletions in patients with conotruncal defects. J Am Coll Cardiol 1998; 32 (02) 492-498
• 7 Botto LD, May K, Fernhoff PM. et al. A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 2003; 112 (1 Pt 1): 101-107
• 8 Momma K, Kondo C, Ando M, Matsuoka R, Takao A. Tetralogy of Fallot associated with chromosome 22q11 deletion. Am J Cardiol 1995; 76 (08) 618-621
• 9 Burn J, Brennan P, Little J. et al. Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet 1998; 351 (9099) 311-316
• 10 Nora JJ, Nora AH. Recurrence risks in children having one parent with a congenital heart disease. Circulation 1976; 53 (04) 701-702
• 11 Andrade AC, Jerosch-Herold M, Wegner P. et al. Determinants of Left Ventricular Dysfunction and Remodeling in Patients With Corrected Tetralogy of Fallot. J Am Heart Assoc 2019; 8 (17) e009618
• 12 Hahn RT, Thomas JD, Khalique OK, Cavalcante JL, Praz F, Zoghbi WA. Imaging Assessment of Tricuspid Regurgitation Severity. JACC Cardiovasc Imaging 2019; 12 (03) 469-490
• 13 Zoghbi WA, Adams D, Bonow RO. et al. Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr 2017; 30 (04) 303-371
• 14 Valente AM, Geva T. How to image repaired Tetralogy of Fallot. Circ Cardiovasc Imaging 2017; 10 (05) c004270
• 15 Valente AM, Cook S, Festa P. et al. Multimodality Imaging Guidelines for Patients with Repaired Tetralogy of Fallot: A Report from the American Society of Echocardiography. Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance and the Society for Pediatric Radiology. J Am Soc Echocardiogr 2014; 27: 111-141
• 16 Baumgartner H, De Backer J, Babu-Narayan SV. et al. ESC Scientific Document Group. ESC Guidelines for the management of adult congenital heart disease: The Task Force for the management of adult congenital heart disease of the European Society of Cardiology (ESC). Eur Heart J 2021; 42 (06) 563-645
• 17 Pelliccia A, Sharma S, Gati S. et al. The Task Force on sports cardiology and exercise in patients with cardiovascular disease of the European Society of Cardiology (ESC). 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J 2021; 42 (01) 17-96
• 18 Geva T. Indications for pulmonary valve replacement in repaired tetralogy of fallot: the quest continues. Circulation 2013; 128 (17) 1855-1857
• 19 Kim YY, Ruckdeschel E. Approach to residual pulmonary valve dysfunction in adults with repaired tetralogy of Fallot. Heart 2016; 102 (19) 1520-1526
• 20 Tweddell JS, Simpson P, Li S-H. et al. Timing and technique of pulmonary valve replacement in the patient with tetralogy of Fallot. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2012; 15 (01) 27-33
• 21 Gatzoulis MA, Balaji S, Webber SA. et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet 2000; 356 (9234) 975-981
• 22 Doyle T, Kavanaugh-McHugh A, Fish FA. Management and outcome of tetralogy of Fallot. Armsby C, Conolly HM, Triedman JK. ed. UpToDate Inc; https://www.uptodate.com/contents/management-and-outcome-of-tetralogy-of-Fallot (abgerufen September 2020)
• 23 Stout KK, Daniels CJ, Aboulhosn JA. et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease. Circulation 2019; 139 (14) e698-e800
• 24 Sachdeva R, Valente AM, Armstrong AK. et al. 2020 appropriate use criteria for multimodality imaging during the follow-up care of patients with congenital heart disease: A Report of ACC/AHA/ASE/HRS/ISACHD/ SCAI/ SCCT/SCMR/SOPE. J Am Coll Cardiol 2020; 75: 657-703
• 25 Tretter JT, Friedberg MK, Wald RM, McElhinney DB. Defining and refining indications for transcatheter pulmonary valve replacement in patients with repaired tetralogy of Fallot: Contributions from anatomical and functional imaging. Int J Cardiol 2016; 221: 916-925
• 26 Eicken A, Ewert P, Hager A. et al. Percutaneous pulmonary valve implantation: two-centre experience with more than 100 patients. Eur Heart J 2011; 32 (10) 1260-5
• 27 Ferraz Cavalcanti PE, Sá MPBO, Lins RFA. et al. Three-step preoperative sequential planning for pulmonary valve replacement in repaired tetralogy of Fallot using computed tomography. Eur J Cardiothorac Surg 2020; 59 (02) 333-340
• 28 Fuller S. Tetralogy of fallot and pulmonary valve replacement: timing and techniques in the asymptomatic patient. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2014; 17 (01) 30-37
• 29 Lawrenz W, Dubowy KO, Baden W, Hager A. Ergometrie und Spiroergometrie bei Kindern und Jugendlichen. Positionspapier der DGPK. http://www.kinderkardiologie.org/fileadmin/user_upload/AGs/PositionspapierErgometrie08_2018.pdf
• 30 Guazzi M, Adams V, Conraads V. et al; EACPR, AHA. EACPR/AHA Joint Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Eur Heart J 2012; 33 (23) 2917-2927
• 31 Takken T, Giardini A, Reybrouck T. et al. Recommendations for physical activity, recreation sport, and exercise training in paediatric patients with congenital heart disease: a report from the Exercise, Basic & Translational Research Section of the European Association of Cardiovascular Prevention and Rehabilitation, the European Congenital Heart and Lung Exercise Group, and the Association for European Paediatric Cardiology. Eur J Prev Cardiol 2012; 19 (05) 1034-1065
• 32 Budts W, Pieles GE, Roos-Hesselink JW. et al. Recommendations for participation in competitive sport in adolescent and adult athletes with Congenital Heart Disease (CHD): position statement of the Sports Cardiology & Exercise Section of the European Association of Preventive Cardiology (EAPC), the European Society of Cardiology (ESC) Working Group on Adult Congenital Heart Disease and the Sports Cardiology, Physical Activity and Prevention Working Group of the Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 2020; 41 (43) 4191-4199
• 33 Chen SSM, Dimopoulos K, Sheehan FH, Gatzoulis MA, Kilner PJ. Physiologic determinants of exercise capacity in patients with different types of right-sided regurgitant lesions: Ebstein's malformation with tricuspid regurgitation and repaired tetralogy of Fallot with pulmonary regurgitation. Int J Cardiol 2016; 205: 1-5
• 34 Dallaire F, Wald RM, Marelli A. The Role of Cardiopulmonary Exercise Testing for Decision Making in Patients with Repaired Tetralogy of Fallot. Pediatr Cardiol 2017; 38 (06) 1097-1105
• 35 Müller J, Hager A, Diller GP. et al. Peak oxygen uptake, ventilatory efficiency and QRS-duration predict event free survival in patients late after surgical repair of tetralogy of Fallot. Int J Cardiol 2015; 196: 158-164
• 36 Diller GP, Dimopoulos K, Okonko D. et al. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation 2005; 112 (06) 828-835
• 37 De Robertis V, Persico N, Volpe G. et al. Tetralogy of Fallot and outlet ventricular septal defect with anterior malalignment detected at early fetal echocardiography. Fetal Diagn Ther 2020; •••: 1-7
• 38 Al Habib HF, Jacobs JP, Mavroudis C. et al; Data from the Society of Thoracic Surgeons Database. Contemporary patterns of management of tetralogy of Fallot: data from the Society of Thoracic Surgeons Database. Ann Thorac Surg 2010; 90 (03) 813-819 , discussion 819–820
• 39 Karl TR. Tetralogy of Fallot: Current surgical perspective. Ann Pediatr Cardiol 2008; 1 (02) 93-100
• 40 Cumming GR. Propranolol in tetralogy of Fallot. Circulation 1970; 41 (01) 13-15
• 41 Ponce FE, Williams LC, Webb HM, Riopel DA, Hohn AR. Propranolol palliation of tetralogy of Fallot: experience with long-term drug treatment in pediatric patients. Pediatrics 1973; 52 (01) 100-108
• 42 Garson Jr A, Gillette PC, McNamara DG. Propranolol: the preferred palliation for tetralogy of Fallot. Am J Cardiol 1981; 47 (05) 1098-1104
• 43 Sluysmans T, Neven B, Rubay J. et al. Early balloon dilatation of the pulmonary valve in infants with tetralogy of Fallot. Risks and benefits. Circulation 1995; 91 (05) 1506-1511
• 44 Qureshi SA, Kirk CR, Lamb RK, Arnold R, Wilkinson JL. Balloon dilatation of the pulmonary valve in the first year of life in patients with tetralogy of Fallot: a preliminary study. Br Heart J 1988; 60 (03) 232-235
• 45 Godart F, Rey C, Prat A. et al. Early and late results and the effects on pulmonary arteries of balloon dilatation of the right ventricular outflow tract in tetralogy of Fallot. Eur Heart J 1998; 19 (04) 595-600
• 46 Wu E-T, Wang J-K, Lee W-L, Chang C-C, Wu M-H. Balloon valvuloplasty as an initial palliation in the treatment of newborns and young infants with severely symptomatic tetralogy of Fallot. Cardiology 2006; 105 (01) 52-56
• 47 Remadevi KS, Vaidyanathan B, Francis E, Kannan BRJ, Kumar RK. Balloon pulmonary valvotomy as interim palliation for symptomatic young infants with tetralogy of Fallot. Ann Pediatr Cardiol 2008; 1 (01) 2-7
• 48 Gewillig M, Boshoff DE, Dens J, Mertens L, Benson LN. Stenting the neonatal arterial duct in duct-dependent pulmonary circulation: new techniques, better results. J Am Coll Cardiol 2004; 43 (01) 107-112
• 49 Schranz D, Michel-Behnke I, Heyer R. et al. Stent implantation of the arterial duct in newborns with a truly duct-dependent pulmonary circulation: a single-center experience with emphasis on aspects of the interventional technique. J Interv Cardiol 2010; 23 (06) 581-588
• 50 Gibbs JL, Uzun O, Blackburn MEC, Parsons JM, Dickinson DF. Right ventricular outflow stent implantation: an alternative to palliative surgical relief of infundibular pulmonary stenosis. Heart 1997; 77 (02) 176-179
• 51 Bertram H, Emmel M, Ewert P. et al; Investigators Of The Working Group Interventional Cardiology Of The German Society Of Pediatric Cardiology. Stenting of Native Right Ventricular Outflow Tract Obstructions in Symptomatic Infants. J Interv Cardiol 2015; 28 (03) 279-287
• 52 Sandoval JP, Chaturvedi RR, Benson L. et al. Right Ventricular Outflow Tract Stenting in Tetralogy of Fallot Infants With Risk Factors for Early Primary Repair. Circ Cardiovasc Interv 2016; 9 (12) e003979
• 53 Quandt D, Ramchandani B, Stickley J. et al. RVOT Stenting Promotes Better PA Growth Than mBTS. JACC Cardiovasc Interv 2017; 10: 1774-1784
• 54 Barron DJ. Tetralogy of Fallot: controversies in early management. World J Pediatr Congenit Heart Surg 2013; 4 (02) 186-191
• 55 Jonas RA. Comprehensive surgical management of congenital heart disease. 1. Auflage. Arnold. London; 2004
• 56 Tchervenkov CI, Pelletier MP, Shum-Tim D, Béland MJ, Rohlicek C. Primary repair minimizing the use of conduits in neonates and infants with tetralogy or double-outlet right ventricle and anomalous coronary arteries. J Thorac Cardiovasc Surg 2000; 119 (02) 314-323
• 57 Voges I, Fischer G, Scheewe J. et al. Restrictive enlargement of the pulmonary annulus at surgical repair of tetralogy of Fallot: 10-year experience with a uniform surgical strategy. Eur J Cardiothorac Surg 2008; 34 (05) 1041-1045
• 58 Uebing A, Fischer G, Bethge M. et al. Influence of the pulmonary annulus diameter on pulmonary regurgitation and right ventricular pressure load after repair of tetralogy of Fallot. Heart 2002; 88 (05) 510-514
• 59 Stewart RD, Backer CL, Young L, Mavroudis C. Tetralogy of Fallot: results of a pulmonary valve-sparing strategy. Ann Thorac Surg 2005; 80 (04) 1431-1438 , discussion 1438–1439
• 60 Frigiola A, Hughes M, Turner M. et al. Physiological and phenotypic characteristics of late survivors of tetralogy of fallot repair who are free from pulmonary valve replacement. Circulation 2013; 128 (17) 1861-1868
• 61 National Institute for Cardiovascular Outcomes (NICOR). Report 2015-18. www.nicor.org.uk/national-cardiac-audit-programme/congenital-heart-disease-in-children-and-adults-congenital-audit/
• 62 Bouzas B, Kilner PJ, Gatzoulis MA. Pulmonary regurgitation: not a benign lesion. Eur Heart J 2005; 26 (05) 433-439
• 63 Burchill LJ, Wald RM, Harris L, Colman JM, Silversides CK. Pulmonary valve replacement in adults with repaired tetralogy of Fallot. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2011; 14 (01) 92-97
• 64 Mongeon FP, Walid Ben SM, Khairy P. et al. Marelli. Pulmonary valve replacement for pulmonary regurgitation in adults with Tetralogy of Fallot: a meta-analysis. Can J Cardiol 2019; 35 (12) 1772-1783
• 65 Von der Muhl IF. Editorial. Timing and results of pulmonary valve replacement for pulmonary regurgitationin repaired Tetralogy of Fallot: a challenge for evidence based medicine. Can J Cardiol 2019; 35 (12) 1623-1625
• 66 Bozkurt B, Coats AJS, Tsutsui H. et al. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association. Eur J Heart Fail 2021; 23 (03) 352-380
• 67 Lurz P, Muthurangu V, Schuler PK. et al. Impact of reduction in right ventricular pressure and/or volume overload by percutaneous pulmonary valve implantation on biventricular response to exercise: an exercise stress real-time CMR study. Eur Heart J 2012; 33 (19) 2434-2441 2434-2441.doi.org/10.1093/eurheartj/ehs200
• 68 Diller GP, Kempny A, Alonso-Gonzalez R. et al. Survival Prospects and Circumstances of Death in Contemporary Adult Congenital Heart Disease Patients Under Follow-Up at a Large Tertiary Centre. Circulation 2015; 132 (22) 2118-2125
• 69 Kapel GFL, Sacher F, Dekkers OM. et al. Arrhythmogenic anatomical isthmuses identified by electroanatomical mapping are the substrate for ventricular tachycardia in repaired Tetralogy of Fallot. Eur Heart J 2017; 38 (04) 268-276
• 70 Walsh EP. Improved understanding of ventricular Tachycardia in patients with tetralogy of Fallot. Eur Heart J 2017; 38 (04) 277-279
• 71 Walsh EP, Cecchin F. Arrhythmias in adult patients with congenital heart disease. Circulation 2007; 115 (04) 534-545
• 72 Egbe AC, Kothapalli S, Borlaug BA. et al. Mechanism and Risk Factors for Death in Adults With Tetralogy of Fallot. Am J Cardiol 2019; 124 (05) 803-807
• 73 Khairy P, Harris L, Landzberg MJ. et al. Implantable cardioverter-defibrillators in tetralogy of Fallot. Circulation 2008; 117 (03) 363-370
• 74 Egbe AC, Adigun R, Anand V. et al. Left ventricular systolic dysfunction and cardiovascular outcomes inTetralogy of Fallot: Systematic review and meta-analysis. Can J Cardiol 2019; 35 (12) 1784-1790
• 75 Geva T, Mulder B, Gauvreau K. et al. Preoperative Predictors of Death and Sustained Ventricular Tachycardia After Pulmonary Valve Replacement in Patients With Repaired Tetralogy of Fallot Enrolled in the INDICATOR Cohort. Circulation 2018; 138 (19) 2106-2115
• 76 Bokma JP, Winter MM, Vehmeijer JT. et al. QRS fragmentation is superior to QRS duration in predicting mortality in adults with tetralogy of Fallot. Heart 2017; 103 (09) 666-671
• 77 Egbe AC, Miranda WR, Mehra N. et al. Role of QRS fragmentation for risk stratification in adults with tetralogy of Fallot. J Am Heart Assoc 2018; 7 (24) e010274
• 78 Wald RM, Valente AM, Marelli A. Heart failure in adult congenital heart disease: Emerging concepts with a focus on tetralogy of Fallot. Trends Cardiovasc Med 2015; 25 (05) 422-432
• 79 Bokma JP, Winter MM, van Dijk AP. et al. Effect of Losartan on right ventricular dysfunction. Circulation 2018; 137 (14) 1463-1471
• 80 Tan JL, Davlouros PAS, McCarthy KP, Gatzoulis MA, Ho SY. Intrinsic histological abnormalities of aortic root and ascending aorta in tetralogy of Fallot: evidence of causative mechanism for aortic dilatation and aortopathy. Circulation 2005; 112 (07) 961-968
• 81 Egbe AC, Miranda WR, Ammash NM. et al. Aortic disease and interventions in adults with tetralogy of Fallot. Heart 2019; 105 (12) 926-931
• 82 Egbe AC, Crestanello J, Miranda WR, Connolly HM. Thoracic Aortic Dissection in Tetralogy of Fallot: A Review of the National Inpatient Sample Database. J Am Heart Assoc 2019; 8 (06) e011943
• 83 Canobbio MM, Warnes CA, Aboulhosn J. et al; American Heart Association Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council on Functional Genomics and Translational Biology, and Council on Quality of Care and Outcomes Research. Management of Pregnancy in Patients With Complex Congenital Heart Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation 2017; 135 (08) e50-e87
• 84 Greutmann M, Pieper PG. Pregnancy in women with congenital heart disease. Eur Heart J 2015; 36 (37) 2491-2499